17 April 2026 -- Munich, Germany -- At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division announces the European launch of MyGenius PRO, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology.

14 April 2026 -- Bagsværd, Denmark -- Novo Nordisk today announced a strategic partnership with OpenAI that will place Novo Nordisk at the forefront of AI transformation in healthcare and help the company bring new and better treatment options to patients faster.

13 April 2026 -- California, US -- At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and automation across research and applied NMR.

8 April 2026 -- Ohio, US -- CAS, a division of the American Chemical Society, today announced the launch of CAS NewtonSM, science-smart agentic AI built specifically for scientific discovery. CAS Newton is grounded in published scientific knowledge curated by CAS scientists, drawing on more than 150 years of literature within the CAS Content CollectionTM to ensure accuracy and scientific rigor.

2 April 2026 -- Paris, France -- Generare – the techbio company generating novel, high-quality molecular data for drug development by decoding what life wrote – has raised €20M in Series A funding co-led by Alven and Daphni with participation from all existing investors, including Galion.exe, Teampact Ventures and VIVES Partners.

31 March 2026 -- Zizers, Switzerland -- Scientists at Purdue University are using the WELLJET dispenser stacker from INTEGRA Biosciences to increase the speed, consistency and scale of drug screening for rare and neglected parasitic diseases. Integrating automated liquid handling into their workflows has allowed the research team to standardize complex screening assays, improve reproducibility and significantly increase throughput.

31 March 2026 -- Cambridge, UK -- Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP).

24 March 2026 -- Cambridge, UK -- Optibrium, a leading developer of software and AI solutions for molecular design, today announced a new QuanSA plugin for PyMOL, providing an intuitive Graphical User Interface (GUI) for its ligand-based binding affinity prediction method, part of the Company’s BioPharmics 3D molecular modelling platform.

19 March 2026 -- Stockholm, Sweden -- Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced a distribution agreement with PrimeTech Co., Ltd., a leading distributor of life science technologies in Japan. The partnership will bring Epigenica’s EpiFinder technologies to researchers and laboratories across the Japanese market.

19 March 2026 -- California, US -- Biotium, a leading provider of fluorescent reagents and kits for life science research, announces the release of the ViaPlex 2-Color Cell Barcoding Kit. Combining fluorescent staining with two reactive dyes, the ViaPlex kit allows researchers to label and combine up to 15 distinct cell populations for multiplex analysis in a single tube, reducing reagent consumption and sample running time without compromising data quality.

17 March 2026 -- Raubling, Germany -- Axplora today announced a major milestone in its $60 million investment programme in highly potent API (HPAPI) manufacturing at its Farmabios site in Gropello Cairoli. The latest phase includes construction of a new 4,500 m², three-storey R&D and laboratory hub, designed to accelerate development, expand execution capacity and deliver cost-efficient high-potency manufacturing at scale.

17 March 2026 -- Paris, France -- DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and BioStream Co., expanding global access to the Company’s SYNTAX? platform for decentralized, in-house and on-demand oligonucleotide production.